JAMA.
6. Cao B, Wang Y, Wen D, et al. 2020. A Trial of Lopinavir-Ritonavir in
Adults Hospitalized with Severe Covid-19. N Engl J Med.
7. Shiraki K, Daikoku T. 2020. Favipiravir, an anti-influenza drug
against life-threatening RNA virus infections. Pharmacol
Ther. 107512.
8. Furuta Y, Takahashi K, Shiraki K, et al. 2009. T-705 (favipiravir)
and related compounds: Novel broad-spectrum inhibitors of RNA viral
infections. Antiviral Res. 82(3):95-102.
9. Cai Q, Yang M, Liu D, et al. 2020. Experimental Treatment with
Favipiravir for COVID-19: An Open-Label Control Study. Engineering
(Beijing).
10. AbbVie Inc. KALETRA HIGHLIGHTS OF PRESCRIBING INFORMATION. 2019.
11. Shi H, Han X, Jiang N, et al. 2020. Radiological findings from 81
patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.